# Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

> **NCT00735644** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 1200 (actual)

## Conditions studied

- Japanese Encephalitis
- Hepatitis A

## Interventions

- **BIOLOGICAL:** Japanese encephalitis vaccine
- **BIOLOGICAL:** Japanese encephalitis vaccine
- **BIOLOGICAL:** Japanese encephalitis vaccine
- **BIOLOGICAL:** Japanese encephalitis vaccine (Acambis)
- **BIOLOGICAL:** Hepatitis A vaccine

## Key facts

- **NCT ID:** NCT00735644
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-05
- **Final completion:** 2009-08
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2015-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735644, "Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00735644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*